BIOMAT Database Logo BIOMAT Database Logo

Bacteriological profile of neonatal septicemia cases (for the year 1990-91). 1994

M Mathur, and H Shah, and K Dixit, and S Khambadkone, and A Chakrapani, and S Irani
Dept of Microbiology, Seth GS Medical College, Parel, Bombay, Maharashtra.

Blood culture reports were studied in 1266 cases of clinically suspected neonatal septicemia, to determine the bacteriological profile and antibiotic sensitivity pattern of the cultured isolates. Blood culture was positive in 24.88% of cases. Gram negative septicemia was encountered in 87.1% of these neonates. Klebsiella and Enterobacter species were the predominant pathogens amongst Gram negative organisms. Of Gram positive isolates, Staphylococcus aureus was the predominant isolate (79.0%). Salmonella species was isolated in 2.4% of these cases.

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D001419 Bacteria One of the three domains of life (the others being Eukarya and ARCHAEA), also called Eubacteria. They are unicellular prokaryotic microorganisms which generally possess rigid cell walls, multiply by cell division, and exhibit three principal forms: round or coccal, rodlike or bacillary, and spiral or spirochetal. Bacteria can be classified by their response to OXYGEN: aerobic, anaerobic, or facultatively anaerobic; by the mode by which they obtain their energy: chemotrophy (via chemical reaction) or PHOTOTROPHY (via light reaction); for chemotrophs by their source of chemical energy: CHEMOLITHOTROPHY (from inorganic compounds) or chemoorganotrophy (from organic compounds); and by their source for CARBON; NITROGEN; etc.; HETEROTROPHY (from organic sources) or AUTOTROPHY (from CARBON DIOXIDE). They can also be classified by whether or not they stain (based on the structure of their CELL WALLS) with CRYSTAL VIOLET dye: gram-negative or gram-positive. Eubacteria
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D016470 Bacteremia The presence of viable bacteria circulating in the blood. Fever, chills, tachycardia, and tachypnea are common acute manifestations of bacteremia. The majority of cases are seen in already hospitalized patients, most of whom have underlying diseases or procedures which render their bloodstreams susceptible to invasion. Bacteremias

Related Publications

M Mathur, and H Shah, and K Dixit, and S Khambadkone, and A Chakrapani, and S Irani
Bacteriological profile of neonatal septicemia.
November 1987, Indian pediatrics,
M Mathur, and H Shah, and K Dixit, and S Khambadkone, and A Chakrapani, and S Irani
Bacteriological profile of neonatal septicemia.
January 1987, Indian pediatrics,
M Mathur, and H Shah, and K Dixit, and S Khambadkone, and A Chakrapani, and S Irani
Bacteriological profile of neonatal septicemia.
January 1988, Indian journal of pediatrics,
M Mathur, and H Shah, and K Dixit, and S Khambadkone, and A Chakrapani, and S Irani
Bacteriological profile and antibiogram of neonatal septicemia.
May 2013, Indian journal of pediatrics,
M Mathur, and H Shah, and K Dixit, and S Khambadkone, and A Chakrapani, and S Irani
Outcome of neonatal septicemia: a clinical and bacteriological profile.
May 1978, Indian pediatrics,
M Mathur, and H Shah, and K Dixit, and S Khambadkone, and A Chakrapani, and S Irani
Neonatal septicemia in calves: 25 cases (1985-1990).
November 1993, Journal of the American Veterinary Medical Association,
M Mathur, and H Shah, and K Dixit, and S Khambadkone, and A Chakrapani, and S Irani
Bacteriological profile of neonatal septicemia and antibiotic susceptibility pattern of the isolates.
July 2013, Journal of natural science, biology, and medicine,
M Mathur, and H Shah, and K Dixit, and S Khambadkone, and A Chakrapani, and S Irani
Bacteriological Profile of Neonatal Septicemia in a Tertiary Care Hospital from Western India.
January 2015, Journal of global infectious diseases,
M Mathur, and H Shah, and K Dixit, and S Khambadkone, and A Chakrapani, and S Irani
Prognosis and treatment of neonatal septicemia-a clinico-bacteriological study of 100 cases.
August 1974, Indian pediatrics,
M Mathur, and H Shah, and K Dixit, and S Khambadkone, and A Chakrapani, and S Irani
Clinico-bacteriological study of neonatal septicemia in Hubli.
March 2000, Indian journal of pediatrics,
Copied contents to your clipboard!